Medicines and Healthcare products Regulatory Agency

An executive agency, also called MHRA

The National Institute for Biological Standards and Control (NIBSC) is part of the Medicines and Healthcare products Regulatory Agency.

250 requests

(page 5)

The response was very full and explanatory. There was the usual disclaimer regarding correlation and cause. Even if some of the cases of adverse effe...
Our Ref: FOI 16/377 Dear Mr Bryan, Thank you for your email of 8 July requesting, under the Freedom of Information Act, how many notifications have...
  Ref No: FOI 16/078 Dear Mr Dean, Thank you for your FOI request to the MHRA on 2nd February 2016.   We are unclear about what you mean by ‘...
Dear Mr Hinks,   Please see attached the response for FOI 15/307.   Kind Regards,     FOI Team,   Vigilance and Risk Management of Me...
Dear Stevan Cirkovic,   Thank you for your email of 7 May 2016 asking the Agency to conduct an internal review of our response to your Freedom of...
Dear Nicola   Thank you for your email of 27 May 2016, requesting information on the Early Access to Medicines Scheme (EAMS) and Promising Innovativ...
Dear Enquirer,   Thank you for your enquiry to the Medicines and Healthcare products Regulatory Agency. This automated response confirms that we hav...
Dear Ms Puertas,   Thank you for your recent request; please find our reply attached. Kind Regards, Customer Services Communications division...
Dear Mr Kelly,         Thank you for your email. Please find attached the response (Part 2 of 2) to your FOI request. Attached in Attached in Part...
13^th April 2016 Ms Grace Olokpa [1][FOI #315747 email]     Dear Ms Olokpa   REF: FOI 16/179   As requested under the Freedom of Info...
Our Ref: FOI 15/089 Dear Mr Wilcock, RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000 Thank you for your enquiry which we received on 24th Feb...
4^th March 2016 [1][FOI #316031 email]         Dear Sir,   REF: FOI 16/106   Thank you for your Freedom of Information request for...
Thank you for your prompt reply. I greatly appreciate your help. Yours sincerely, Ben Creasey
WHAT WAS THE POINT OF BANNING CO-PROXAMOL? Deaths involving Co-codamol (paracetamol and codeine) increased by 21% in 2014 to a new high of 63 deaths....
Our Ref: FOI 15/647     Dear Mr Pritchard,   Re:   Freedom of Information Request ' Vaccines and Drugs containing aluminium hydroxide '          ...
Ref No: FOI 15/627   Dear Mr Dorn,   Thank you for your email of 16 December 2015 requesting details of ''how many applications for an MA were rec...
7^th December 2015 Alli Katzen [1][FOI #301882 email]       Dear Alli Katzen   REF:  FOI  15/569   I am writing in response to your...
Dear Ms Brunsden,         Thank you for your email. Please find attached the response to your FOI request.         Kind Regards, Customer Servic...
Dear S Patel, Thank you for your email. Our Inspection, Enforcement and Standards division experts advise 'Yes' your understanding of the first point...
19/11/2015 Mrs Wingrove [1][FOI #302075 email]       Dear Mrs Wingrove   REF:  FOI 15/570   Thank you for your communication to the...
Dear Enquirer,   Thank you for your enquiry to the Medicines and Healthcare products Regulatory Agency. This automated response confirms that we hav...
Dear Enquirer,   Thank you for your enquiry to the Medicines and Healthcare products Regulatory Agency. This automated response confirms that we hav...
Dear Ms Ryalls,         Thank you for your email. Please find attached the response to your FOI request.         Kind Regards, Customer Service...
Drug approval dates
Follow up sent to Medicines and Healthcare products Regulatory Agency by Anna Smith on .

Successful.

Dear Mr Goddard This is brilliant! Thank you very much. Yours sincerely, Anna Smith
Ref No: FOI 15/335 & FOI 15/342 Dear Ms Carly Green,   Thank you for your emails of 2nd and 7th July 2015 requesting information on Microsoft Of...

Only requests made using WhatDoTheyKnow are shown. ?